Status:
COMPLETED
French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Pneumonia, Viral
Critically Ill
Eligibility:
All Genders
18+ years
Brief Summary
Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from China to other countries causing an international outbreak of respiratory illnesses named COVID-19. In Fran...
Eligibility Criteria
Inclusion
- Patients admitted to ICU for suspected or proven SARS-Cov-2 infection, defined by positive SARS-Cov-2 PCR or CT scan images
- Patient \> or= 18 years
Exclusion
- Patient study refusal
- Patient already enrolled in the present study
- Patient with respiratory illness with negative COVID-19 CT scan images and negative COVID\_19 PCR
Key Trial Info
Start Date :
April 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2020
Estimated Enrollment :
1003 Patients enrolled
Trial Details
Trial ID
NCT04340466
Start Date
April 3 2020
End Date
July 3 2020
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nimes
Nîmes, France, 30029